Why Johnson & Johnson (JNJ) is Back on Investors’ Radar Johnson & Johnson (JNJ) has drawn fresh attention after recent ...

JNJ stock price today: Johnson & Johnson stock saw a dip even as the company projected robust 2026 sales and profit figures.

Johnson & Johnson (NYSE:JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21. Analysts expect the company to report fourth-quarter earnings of $2.47 per ...

Johnson & Johnson reports Q4 earnings Jan 21 with 22% EPS growth expected. Stelara biosimilars and talc verdict weigh on ...

Johnson & Johnson (JNJ) closed the most recent trading day at $209.72, moving +2.61% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.16%. On the other hand, the Dow ...

If you are wondering whether Johnson & Johnson is reasonably priced at its recent levels, you are not alone. Many investors ...

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is ...

Johnson & Johnson's (NYSE: JNJ) stock price is up more than 7% since the first trading day of November. What's going on with this healthcare giant? Well, J&J posted strong third-quarter results in mid ...

Johnson & Johnson’s post-Kenvue shift boosts growth and free cash flow, with an elite balance sheet but mixed revisions.

Last month, Johnson & Johnson surged following a well-received quarterly earnings release. Despite a sluggish start to November, a spate of positive news has since sent the healthcare stock's shares ...

Johnson & Johnson (NYSE:JNJ) is among the most profitable US stocks to buy. On January 9, Lee Hambright at Bernstein raised ...

J&J beat Wall Street estimates on sales and profits in the third quarter. The company recently announced the acquisition of a biotech with an innovative cancer treatment. 10 stocks we like better than ...